Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

NCT06526299 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Lutetium Lu 177 Vipivotide Tetraxetan
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: PSMA PET-CT Scan
OTHER: Questionnaire Administration
PROCEDURE: Single Photon Emission Computed Tomography

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]